Quantum Cyber N.V. Adjustments For Decrease Increase In Inventories
Quantum Cyber N.V. (QUCY) reported Adjustments For Decrease Increase In Inventories of -$112.19 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Notes › Inventory
ifrs-full:AdjustmentsForDecreaseIncreaseInInventories · last filed 2025-09-26
- Quantum Cyber N.V. adjustments for decrease increase in inventories for the quarter ending 2023-12-31 was $158.13K, a 4.29% decline year-over-year.
- Quantum Cyber N.V. adjustments for decrease increase in inventories for the quarter ending 2023-09-30 was $550.42K, a 1111.74% increase year-over-year.
- Quantum Cyber N.V. adjustments for decrease increase in inventories for the quarter ending 2023-06-30 was -$121.05K.
- Quantum Cyber N.V. adjustments for decrease increase in inventories for the quarter ending 2023-03-31 was -$87.31K.
| Period end | Adjustments For Decrease Increase In Inventories 3 month | Adjustments For Decrease Increase In Inventories 6 month | Adjustments For Decrease Increase In Inventories 9 month | Adjustments For Decrease Increase In Inventories 12 month | Adjustments For Decrease Increase In Inventories 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | -$112.19K 6-K · filed 2025-09-26 | ||||
| 2024-12-31 | -$29.81K 20-F · filed 2025-03-31 | ||||
| 2024-06-30 | $8.27K 6-K · filed 2025-09-26 | ||||
| 2023-12-31 | $158.13K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $708.55K derived: sum of 2 quarters · filed 2025-03-31 | $587.50K derived: sum of 3 quarters · filed 2025-03-31 | $500.19K 20-F · filed 2025-03-31 | |
| 2023-09-30 | $550.42K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $429.37K derived: sum of 2 quarters · filed 2024-10-18 | $342.06K 6-K · filed 2023-11-16 | $507.28K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-06-30 | -$121.05K derived: 6-K 6 month − 6-K 3 month · filed 2024-10-18 | -$208.37K 6-K · filed 2024-10-18 | -$43.15K derived: sum of 3 quarters · filed 2025-03-31 | $2.28K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-03-31 | -$87.31K 6-K · filed 2023-05-16 | $77.91K derived: sum of 2 quarters · filed 2025-03-31 | $123.33K derived: sum of 3 quarters · filed 2025-03-31 | ||
| 2022-12-31 | $165.22K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $210.65K derived: sum of 2 quarters · filed 2025-03-31 | $172.38K 20-F · filed 2025-03-31 | -$172.38K 20-F · filed 2023-04-07 | |
| 2022-09-30 | $45.42K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $7.16K 6-K · filed 2023-11-16 | |||
| 2022-06-30 | -$38.27K 6-K · filed 2023-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |